{
    "organizations": [],
    "uuid": "09140b12c45d9a0b9be0221473b6c8b2b26e1c35",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alligator-bioscience-contracts-the/brief-alligator-bioscience-contracts-theradex-oncology-as-clinical-cro-idUSFWN1PK04C",
    "ord_in_thread": 0,
    "title": "BRIEF-Alligator Bioscience Contracts Theradex Oncology As Clinical CRO",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 25 (Reuters) - ALLIGATOR BIOSCIENCE AB:\n* ALLIGATOR BIOSCIENCE CONTRACTS THERADEX ONCOLOGY AS CLINICAL CRO FOR THE UPCOMING ATOR-1015 PHASE I STUDY\n* STUDY IS EXPECTED TO COMMENCE IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-25T15:40:00.000+02:00",
    "crawled": "2018-01-26T21:42:08.056+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "alligator",
        "bioscience",
        "ab",
        "alligator",
        "bioscience",
        "contract",
        "theradex",
        "oncology",
        "clinical",
        "cro",
        "upcoming",
        "phase",
        "study",
        "study",
        "expected",
        "commence",
        "second",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}